Schedule 13G ownership disclosure
Prevail Therapeutics Inc.
Security class unavailable · CUSIP: 74140Y101
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,248,306
- Percent of class
- 6.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-20-000149
- Form type
- SC 13G
- Filer
- EcoR1 Capital, LLC
- CIK
- CIK 1587114
- Filed
- Feb 14, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership